Performance of the new clinical case definitions of pertussis in pertussis suspected infection and other diagnoses similar to pertussis

Mioljub Ristić, Biljana Radosavljević, Vesna D Stojanović, Milan Đilas, Vladimir Petrović, Mioljub Ristić, Biljana Radosavljević, Vesna D Stojanović, Milan Đilas, Vladimir Petrović

Abstract

Background: In an effort to improve the pertussis diagnosis, the Global Pertussis Initiative (GPI) proposed an algorithm of the signs/symptoms of pertussis for three age groups: 0-3 months, 4 months to 9 years, and ≥10 years of age.

Methods: We evaluated the accuracy of the clinical case definitions for pertussis proposed by the GPI using laboratory-confirmed pertussis as a reference standard for four groups: clinically suspected pertussis without comorbidity; asthma exacerbation; allergic constitution, and other diagnoses (bronchitis, bronchiolitis, laryngitis, and tracheitis). We included only patients who fulfilled one or more criteria of clinical case definitions for the age groups (0-3 months, 4 months-9 years, and ≥10 years of age). The data for this prospective epidemiological study were collected between 1st January 2013-31st December 2016 at the outpatients and inpatients health care settings in the South Bačka District of Autonomous Province of Vojvodina, Serbia. We evaluated accuracy of the certain sign and symptom combinations of GPI case definitions based on their sensitivity, specificity, and likelihood ratios.

Results: A total of 1043 participants were included, with 306 (29.3%) laboratory-confirmed pertussis cases. In patients aged 0-3 months, whoop and apnoea associated with laboratory confirmation of pertussis. In patients aged 4 months-9 years with a pertussis suspicion infection or with one of the other diagnoses, the highest accuracy was found for whoop combined with apnoea or post-tussive emesis. In patients aged 10 years and older, several different sign and symptom combinations were associated with an increased risk of pertussis among all enrolment diagnoses. There were fewer hospitalizations among the fully vaccinated children than in partly or unvaccinated children aged 4 months to 6 years (20.7% vs. 60.0%, p = 0.017).

Conclusions: The numerous sign and symptom combinations in the observed case definitions were good predictors for laboratory-confirmed pertussis among all enrolment diagnoses, therefore suggesting the necessity for increased awareness of possibility for pertussis in patients with certain pertussis-like medical conditions.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Algorithm for the surveillance and…
Fig 1. Algorithm for the surveillance and laboratory diagnosis of pertussis.
a Clinical case definition and procedures for laboratory confirmation in accordance with the recommendations of the Global Pertussis Initiative (GPI) (Cherry at all, Clinical Definitions of Pertussis: Summary of a Global Pertussis Initiative Roundtable Meeting, February 2011. Clinical Infectious Diseases Advance Access published May 4, 2012); b Other diagnoses included bronchitis, bronchiolitis, laryngitis or tracheitis. PCR: polymerase chain reaction; IgG: immunoglobin G; PT: pertussis toxin.

References

    1. World Health Organization. Pertussis vaccines: WHO position paper, August 2015—Recommendations. Vaccine. 2016; 34(12):1423–5. 10.1016/j.vaccine.2015.10.136 .
    1. Edwards K, Decker MD. Whooping cough vaccine In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines. 6th ed Philadelphia: Elsevier; 2013. Pp. 447–92.
    1. Ghanaie RM, Karimi A, Sadeghi H, Esteghamti A, Falah F, Armin S, et al. Sensitivity and specificity of the World Health Organization pertussis clinical case definition. Int J Infect Dis. 2010; 14: e1072–5.
    1. Koh MT, Liu CS, Chiu CH, Boonsawat W, Watanaveeradej V, Abdullah N, et al. Under-recognized pertussis in adults from Asian countries: a cross-sectional seroprevalence study in Malaysia, Taiwan and Thailand. Epidemiol Infect. 2016; 144:1192–200.
    1. Cherry JD, Tan T, Wirsing von König CH, Forsyth KD, Thisyakorn U, Greenberg D, et al. Clinical definitions of pertussis: Summary of a Global Pertussis Initiative roundtable meeting, February 2011. Clin Infect Dis. 2012; 54:1756–64. 10.1093/cid/cis302 .
    1. Wessels MR, Brigham KS, DeMaria A Jr. Case records of the Massachusetts General Hospital. Case 6–2015. A 16-year-old boy with coughing spells. N Engl J Med. 2015; 372:765–73. .
    1. Institute of Public Health of Vojvodina. [Communicable diseases in Vojvodina, 2015. Annual report]. Novi Sad: Institute of Public Health of Vojvodina; 2016. Pp. 112–16. Serbian.
    1. Petrović V, Šeguljev Z, Ristić M, Radosavljević B, Đilas M, Heininger U. Pertussis incidence rates in Novi Sad (Serbia) before and during improved surveillance. Srp Arh Celok Lek. 2017;145(3–4):165–72.
    1. Heininger U, André P, Chlibek R, Kristufkova Z, Kutsar K, Mangarov A, et al. Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000–2013. PLoS One. 2016; 11(6): e0155949 10.1371/journal.pone.0155949 .
    1. Pravilnik o imunizaciji i načinu zaštite lekovima. Službeni glasnik Republike Srbije, broj 11/2006, 25/2013, 63/2013, 99/2013, 118/2013, 65/2014 i 32/2015. Serbian.
    1. Swets JA. Measuring the accuracy of diagnostic systems. Science. 1988; 240(4857):1285–93. .
    1. Thompson M, Vodicka TA, Blair PS, Buckley DI, Heneghan C, Hay AD. Duration of symptoms of respiratory tract infections in children: systematic review. BMJ. 2013; 347: f7027 10.1136/bmj.f7027 .
    1. Khoshoo V, Edell D, Mohnot S, Haydel R Jr, Saturno E, Kobernick A. Associated factors in children with chronic cough. Chest. 2009; 136:811–5. 10.1378/chest.09-0649 .
    1. Tarlo SM. Cough: occupational and environmental considerations: ACCP evidence-based clinical practice guidelines. Chest. 2006; 129(1 Suppl):186S–196S. 10.1378/chest.129.1_suppl.186S .
    1. Braman SS. Postinfectious Cough ACCP Evidence-Based Clinical Practice Guidelines. Chest. 2006; 129(1 Suppl):138S–146S. 10.1378/chest.129.1_suppl.138S .
    1. Lasserre A, Laurent E, Turbelin C, Hanslik T, Blanchon T, Guiso N. Pertussis incidence among adolescents and adults surveyed in general practices in the Paris area, France, May 2008 to March 2009. Euro Surveill. 2011; 16(5). pii: 19783. .
    1. Capili CR, Hettinger A, Rigelman-Hedberg N, Fink L, Boyce T, Lahr B, et al. Increased risk of pertussis in patients with asthma. J Allergy Clin Immunol. 2012; 129(4):957–63.
    1. Harnden A, Grant C, Harrison T, Perera R, Brueggemann AB, Mayon-White R, et al. Whooping cough in school age children with persistent cough: prospective cohort study in primary care. BMJ. 2006; 333:174–7.
    1. Kilgore PE, Salim AM, Zervos MJ, Schmitt HJ. Pertussis: Microbiology, Disease, Treatment, and Prevention. Clin Microbiol Rev. 2016;29(3):449–86. 10.1128/CMR.00083-15 .
    1. Crespo I, Cardeñosa N, Godoy P, Carmona G, Sala MR, Barrabeig I, et al. Epidemiology of pertussis in a country with high vaccination coverage. Vaccine. 2011. 6; 29(25):4244–8.
    1. Wymann MN, Richard JL, Vidondo B, Heininger U. Prospective pertussis surveillance in Switzerland, 1991–2006. Vaccine. 2011; 29(11):2058–65. 10.1016/j.vaccine.2011.01.017 .
    1. Wearing HJ, Rohani P. Estimating the duration of pertussis immunity using epidemiological signatures. PLoS Pathog. 2009;5(10): e1000647 10.1371/journal.ppat.1000647 .
    1. Lugauer S, Heininger U, Cherry JD, Stehr K. Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine. Eur J Pediatr. 2002; 161(3):142–6. .
    1. Torvaldsen S, Simpson JM, McIntyre PB. Effectiveness of pertussis vaccination in New South Wales, Australia, 1996–1998. Eur J Epidemiol. 2003; 18(1):63–9. .
    1. Gustafsson L, Hessel L, Storsaeter J, Olin P. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age. Pediatrics. 2006; 118(3):978–84. 10.1542/peds.2005-2746 .
    1. Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of 600 acellular pertussis vaccine in children. N Engl J Med. 2012; 367(11):1012–9. 601 10.1056/NEJMoa1200850 .
    1. Crespo I, Toledo D, Soldevila N, Jordán I, Solano R, Castilla J, et al. Characteristics of Hospitalized 551 Cases of Pertussis in Catalonia and Navarra, Two Regions in the North of Spain. PLoS One. 2015; 552 10: e0139993 10.1371/journal.pone.0139993 .

Source: PubMed

3
S'abonner